As of the latest Form 4 filed Jun 22, 2026.
What Palvella Therapeutics, Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 23 most recent filings for PVLA.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-22 | 2026-06-17 | Goin Kathleen Chief Operating Officer | SSale | −25.00 | $112.23 | $2.81K | Yes (planned) | Form 4 ↗ |
| 2026-06-22 | 2026-06-17 | Goin Kathleen, Chief Operating Officer | SSale | −1.89K | $111.31 | $210K | Yes (planned) | Form 4 ↗ |
| 2026-06-22 | 2026-06-17 | Goin Kathleen, Chief Operating Officer | SSale | −2.39K | $110.26 | $264K | Yes (planned) | Form 4 ↗ |
| 2026-06-22 | 2026-06-17 | Goin Kathleen, Chief Operating Officer | MExercise | +2.15K | $9.08 | $19.5K | Yes (planned) | Form 4 ↗ |
| 2026-06-22 | 2026-06-17 | Goin Kathleen, Chief Operating Officer | MExercise | +2.15K | $7.14 | $15.4K | Yes (planned) | Form 4 ↗ |
| 2026-06-16 | 2026-06-12 | Korenberg Matthew E CFO, Treasurer | MExercise | +1.00K | $13.60 | $13.6K | No | Form 4 ↗ |
| 2026-04-17 | 2026-04-15 | Goin Kathleen Chief Operating Officer | SSale | −100.00 | $130.33 | $13.0K | Yes (planned) | Form 4 ↗ |
| 2026-04-17 | 2026-04-15 | Goin Kathleen, Chief Operating Officer | SSale | −639.00 | $129.17 | $82.5K | Yes (planned) | Form 4 ↗ |
| 2026-04-17 | 2026-04-15 | Goin Kathleen, Chief Operating Officer | SSale | −561.00 | $128.23 | $71.9K | Yes (planned) | Form 4 ↗ |
| 2026-04-17 | 2026-04-15 | Goin Kathleen, Chief Operating Officer | SSale | −1.50K | $127.13 | $191K | Yes (planned) | Form 4 ↗ |
| 2026-04-17 | 2026-04-15 | Goin Kathleen, Chief Operating Officer | SSale | −1.50K | $125.96 | $189K | Yes (planned) | Form 4 ↗ |
| 2026-04-17 | 2026-04-15 | Goin Kathleen, Chief Operating Officer | MExercise | +2.15K | $9.08 | $19.5K | Yes (planned) | Form 4 ↗ |
| 2026-04-17 | 2026-04-15 | Goin Kathleen, Chief Operating Officer | MExercise | +2.15K | $7.14 | $15.4K | Yes (planned) | Form 4 ↗ |
| 2026-04-01 | 2026-03-30 | JENKINS GEORGE M Director | PPurchase | +445.00 | $112.30 | $50.0K | No | Form 4 ↗ |
| 2026-03-20 | 2026-03-18 | Goin Kathleen Chief Operating Officer | SSale | −304.00 | $119.08 | $36.2K | Yes (planned) | Form 4 ↗ |
| 2026-03-20 | 2026-03-18 | Goin Kathleen, Chief Operating Officer | SSale | −1.73K | $118.37 | $205K | Yes (planned) | Form 4 ↗ |
| 2026-03-20 | 2026-03-18 | Goin Kathleen, Chief Operating Officer | SSale | −2.27K | $117.56 | $267K | Yes (planned) | Form 4 ↗ |
| 2026-03-20 | 2026-03-18 | Goin Kathleen, Chief Operating Officer | MExercise | +2.15K | $9.08 | $19.5K | Yes (planned) | Form 4 ↗ |
| 2026-03-20 | 2026-03-18 | Goin Kathleen, Chief Operating Officer | MExercise | +2.15K | $7.14 | $15.4K | Yes (planned) | Form 4 ↗ |
| 2026-01-23 | 2026-01-21 | Goin Kathleen Chief Operating Officer | SSale | −3.75K | $97.94 | $367K | Yes (planned) | Form 4 ↗ |
| 2026-01-23 | 2026-01-21 | Goin Kathleen, Chief Operating Officer | SSale | −553.00 | $95.49 | $52.8K | Yes (planned) | Form 4 ↗ |
| 2026-01-23 | 2026-01-21 | Goin Kathleen, Chief Operating Officer | MExercise | +2.15K | $9.08 | $19.5K | Yes (planned) | Form 4 ↗ |
| 2026-01-23 | 2026-01-21 | Goin Kathleen, Chief Operating Officer | MExercise | +2.15K | $7.14 | $15.4K | Yes (planned) | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also PVLA’s full analysis or the market-wide insider trading feed. The tabs above jump to PVLA’s other SEC data.
Source: SEC Form 4 filings for PVLA, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.